| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029003 |
| Receipt No. | R000033185 |
| Official scientific title of the study | Percutaneous periarticular analgesic injection at one day after total knee arthroplasty as a component of multimodal pain management: a randomized control trial |
| Date of disclosure of the study information | 2017/09/05 |
| Last modified on | 2019/02/09 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Percutaneous periarticular analgesic injection at one day after total knee arthroplasty as a component of multimodal pain management: a randomized control trial | |
| Title of the study (Brief title) | Percutaneous periarticular analgesic injection at one day after total knee arthroplasty as a component of multimodal pain management: a randomized control trial | |
| Region |
|
|
| Condition | ||
| Condition | Osteoarthritis, Avascular necrosis of femoral condyle, Rheumatoid arthritis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the impact of percutaneous periarticular analgesic injection at one day after total knee arthroplasty on multimodal pain management. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visual Analogue Scale for postoperative pain at rest measured at 12:00 and 20:00 of one day after surgery, and 6:00, 12:00, and 20:00 of two to five days after surgery. |
| Key secondary outcomes | Complication
Visual Analogue Scale during activity (measured at one to five days after surgery) Range of knee movement (measured at one to five days after surgery) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Percutaneous periarticular analgesic injection including methylprednisolone 40 mg [1 mL], ropivacaine 150 mg [20 mL], and epinephrine 0.1 mg [0.1 mL] at one day after total knee arthroplasty | |
| Interventions/Control_2 | No percutaneous periarticular analgesic injection at one day after total knee arthroplasty | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients scheduled for unilateral total knee arthroplasty | |||
| Key exclusion criteria | Patients scheduled for simultaneous bilateral total knee arthroplasty.
Patients scheduled for unilateral total knee arthroplasty combined with implant removal. Patients who had allergy or intolerance to one of the study drugs. Patients who had poorly controlled diabetic mellitus. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Motohiro Wakui |
| Organization | Nekoyama Miyao Hospital |
| Division name | Orthopaedic Surgery |
| Address | 14-7 Konan, Chuo-ku, Niigata |
| TEL | +81252822323 |
| m-wakui@nekoyama.or.jp | |
| Public contact | |
| Name of contact person | Sachiyuki Tsukada |
| Organization | Nekoyama Miyao Hospital |
| Division name | Orthopaedic Surgery |
| Address | 14-7 Konan, Chuo-ku, Niigata |
| TEL | +81252822323 |
| Homepage URL | |
| s8058@nms.ac.jp | |
| Sponsor | |
| Institute | Nekoyama Miyao Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-019-2451-1 |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033185 |